Physician profile
Mitchell L Koerber
NPI 1801851316
$1,793.31
in general payments reported to CMS, 2019-2025
16 companies · $531 in 2025
The $531 reported for 2025 was more than what a typical Corneal and Contact Management provider received nationally (typical 2025 total: $227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.66 · 2020: $25.00 · 2021: $292 · 2022: $139 · 2023: $389 · 2024: $322 · 2025: $531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,227 · Entertainment: $15.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,227.19 |
| Entertainment | $15.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $619.42 | 2022-2025 | Infuse, Miebo, Xiidra |
| Alcon Vision LLC | $261.20 | 2022-2025 | Total30, Precision7, Precision 1 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $161.91 | 2019-2021 | |
| Lkc Technologies, INC. | $159.37 | 2023-2024 | |
| Dompe US, INC. | $137.16 | 2021-2025 | Oxervate |
| Johnson & Johnson Vision Care, INC. | $104.98 | 2021 | |
| Kala Pharmaceuticals, INC. | $79.68 | 2021-2022 | |
| Allergan, INC. | $58.05 | 2021-2022 | |
| Tarsus Pharmaceuticals, INC. | $55.79 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $39.60 | 2022 | |
| Coopervision INC. | $25.08 | 2025 | Myday Contact Lens |
| Thea Pharma INC. | $22.43 | 2024 | Iyuzeh |
| Sun Pharmaceutical Industries INC. | $21.52 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $16.13 | 2022 | |
| Biotissue Holdings INC. | $15.94 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $15.05 | 2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Koerber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.